213 related articles for article (PubMed ID: 10727442)
1. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.
Yu Q; Shao R; Qian HS; George SE; Rockey DC
J Clin Invest; 2000 Mar; 105(6):741-8. PubMed ID: 10727442
[TBL] [Abstract][Full Text] [Related]
2. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
[TBL] [Abstract][Full Text] [Related]
4. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
Rockey DC; Chung JJ
Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
[TBL] [Abstract][Full Text] [Related]
6. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.
Morales-Ruiz M; Cejudo-Martín P; Fernández-Varo G; Tugues S; Ros J; Angeli P; Rivera F; Arroyo V; Rodés J; Sessa WC; Jiménez W
Gastroenterology; 2003 Aug; 125(2):522-31. PubMed ID: 12891555
[TBL] [Abstract][Full Text] [Related]
7. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
8. [Akt gene therapy for cirrhotic rats with portal hypertension].
Huang FZ; Deng G; Liu XY; Luo CQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
[TBL] [Abstract][Full Text] [Related]
9. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
[TBL] [Abstract][Full Text] [Related]
10. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
[TBL] [Abstract][Full Text] [Related]
11. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
[TBL] [Abstract][Full Text] [Related]
12. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance.
Rockey DC; Weisiger RA
Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268
[TBL] [Abstract][Full Text] [Related]
13. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
Wang H; Chen XP; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
Biecker E; Neef M; Sägesser H; Shaw S; Koshy A; Reichen J
Liver Int; 2004 Aug; 24(4):345-53. PubMed ID: 15287858
[TBL] [Abstract][Full Text] [Related]
15. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of endothelial nitric oxide synthase maintains nitric oxide production in the cerebellum of thioacetamide cirrhotic rats.
Hernández R; Martínez-Lara E; Del Moral ML; Blanco S; Cañuelo A; Siles E; Esteban FJ; Pedrosa JA; Peinado MA
Neuroscience; 2004; 126(4):879-87. PubMed ID: 15207323
[TBL] [Abstract][Full Text] [Related]
17. High-frequency vagus nerve stimulation improves portal hypertension in cirrhotic rats.
Bockx I; Verdrengh K; Vander Elst I; van Pelt J; Nevens F; Laleman W; Cassiman D
Gut; 2012 Apr; 61(4):604-12. PubMed ID: 22187073
[TBL] [Abstract][Full Text] [Related]
18. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
